A recent ₦21 billion rights issue from a leading domestic manufacturer has sent a clear and powerful signal across the continent's investment landscape, suggesting a profound transformation is underway within Nigeria's pharmaceutical sector. This move is more than just a successful capital raise;
The intricate, monolithic metal components powering rockets and deep-sea drilling rigs are often manufactured using methods that defy traditional assembly, raising the question of how such singular, complex structures are brought into existence. The answer lies not on a desktop or in a small
The Race for a New Generation of Medicines The biopharmaceutical landscape is in the midst of a revolution, driven by the unprecedented potential of gene therapies and mRNA vaccines. These advanced therapies promise to treat, and even cure, diseases once considered intractable. However, their
The immense and often overlooked environmental footprint of disposable hygiene products has long presented a complex recycling challenge that traditional methods have struggled to address, leaving a significant waste stream destined for landfills or incineration. A pioneering collaborative
In an industry where craftsmanship and heritage often intersect with modern production demands, the role of human resources professionals extends far beyond traditional administrative duties, encompassing the unique challenges of talent retention, skills development, and navigating complex
A New Era of Onshoring: Lillys Multi-Billion-Dollar Manufacturing Pivot In a striking departure from decades of industry practice, pharmaceutical giant Eli Lilly is executing a profoundly confident and expensive strategic realignment by committing over $50 billion over the past five years to expand
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53